4//SEC Filing
McFarlane Neil F. 4
Accession 0001437749-25-002623
CIK 0001434647other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:19 PM ET
Size
7.1 KB
Accession
0001437749-25-002623
Insider Transaction Report
Form 4
McFarlane Neil F.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-01-31−233,333→ 466,667 total→ Common Stock (233,333 underlying) - Exercise/Conversion
Common Stock
2025-01-31+233,333→ 283,333 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001681098
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:19 PM ET
- Size
- 7.1 KB